Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir

Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons

(2011) Andy I Choi et al.   AIDS

Abacavir use and cardiovascular disease events

(2011) Mario Cruciani et al.   AIDS

High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors

(2011) Elisabeth Aslangul et al.   AIDS

T cell activation predicts carotid artery stiffness among HIV-infected women

(2011) Robert C. Kaplan et al.   ATHEROSCLEROSIS

Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir

(2011) Authors: Sergio Padilla et al.   BMC INFECTIOUS DISEASES

Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s

(2011) G. A. McComsey et al.   CLINICAL INFECTIOUS DISEASES

Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québecʼs Public Health Insurance Database

(2011) Madeleine Durand et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

(2011) Grace A. McComsey et al.   JOURNAL OF INFECTIOUS DISEASES

Platelet function and HIV: a case–control study

(2010) Claudette S Satchell et al.   AIDS

Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

(2010) Allison Martin et al.   AIDS

Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction

(2010) Esteban Martínez et al.   AIDS

Inflammatory biomarkers and abacavir use in the Womenʼs Interagency HIV Study and the Multicenter AIDS Cohort Study

(2010) Frank J Palella et al.   AIDS

Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus–Infected PatientsA Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4Antiretroviral Drugs, Risk of MI, and HIV

(2010) Sylvie Lang   ARCHIVES OF INTERNAL MEDICINE

Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children

(2010) Allison C. Ross et al.   ATHEROSCLEROSIS

Differential Effects of Efavirenz and Lopinavir/Ritonavir on Human Adipocyte Differentiation, Gene Expression and Release of Adipokines and Pro-Inflammatory Cytokines.

(2010) Jose M. Gallego-Escuredo et al.   CURRENT HIV RESEARCH

Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy

(2010) T. T. Brown et al.   DIABETES CARE

Effects of Third-Generation Oral Contraceptives on High-Sensitivity C-reactive Protein and Homocysteine in Young Women

(2010) Sabina Cauci et al.   OBSTETRICS AND GYNECOLOGY

Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima‐Media Thickness in HIV‐Infected Patients Receiving Antiretroviral Therapy

(2009) Allison C. Ross et al.   CLINICAL INFECTIOUS DISEASES

Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study

(2009) N Obel et al.   HIV MEDICINE

Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects

(2009) Cindy H Brothers et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen

(2009) Todd T Brown et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

(2009) Signe Westring Worm et al.   JOURNAL OF INFECTIOUS DISEASES

Abacavir and Cardiovascular Risk in HIV‐Infected Patients: Does T Lymphocyte Hyperactivation Exert a Pathogenic Role?

(2008) Giulia Marchetti et al.   CLINICAL INFECTIOUS DISEASES

Association of HIV Infection and HIV/HCV Coinfection With C-Reactive Protein Levels

(2008) Jason S Reingold et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Body weight and oral contraceptives are the most important modulators of serum CRP levels

(2008) S. Buchbinder et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

(2008) Lewis H Kuller et al.   PLOS MEDICINE